Evogene Ltd. Logo

Evogene Ltd.

EVGN | TA

Overview

Corporate Details

ISIN(s):
IL0011050551
LEI:
Country:
Israel
Address:
13 Gad Feinstein St., Park Rehovot, 7638517 Rehovot
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Evogene develops computational predictive biology solutions for agriculture, health, and sustainability.

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-07-29 16:00
Earnings Release
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 217.6 KB
2025-07-29 16:00
Regulatory News Service
Schedules Second Quarter 2025 Financial Results Release and Zoom conference call
English 36.5 KB
2025-07-18 01:00
Proxy Solicitation & Information Statements
Other Report or Announcement
English 180.7 KB
2025-07-18 01:00
Regulatory News Service
Other Report or Announcement
English 36.7 KB
2025-07-08 16:00
Takeover Announcement Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 173.8 KB
2025-07-08 16:00
Foreign Filer Report
Evogene Announces Completion of Transaction for the Sale of Lavie Bio’s Activit…
English 36.6 KB
2025-06-18 01:01
Foreign Filer Report
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 708.7 KB
2025-06-18 01:01
AGM Report
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON AUGUST 11, 2025
English 36.4 KB
2025-06-18 01:00
Proxy Solicitation & Information Statements
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
Proxy Solicitation & Information Statements
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 708.7 KB
2025-06-18 01:00
General Meeting Notice
Immediate Report of Meeting to be held on Auguest 11, 2025, proxy statement
English 140.8 KB
2025-06-10 16:00
Regulatory News Service
Evogene Announces Completion of First-In-Class Foundation Model for Generative …
English 621.6 KB
2025-06-10 16:00
Foreign Filer Report
Evogene Announces Completion of First-In-Class Foundation Model for Generative …
English 36.4 KB
2025-06-06 01:00
Foreign Filer Report
Biomica- Update : Changes in management; Will significantly reduce its internal…
English 81.0 KB
2025-06-06 01:00
Foreign Filer Report
Biomica- Update : Changes in management; Will significantly reduce its internal…
English 36.3 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
1NKEMIA Logo 1NKEMIA Spain IKM
2cureX AB Logo 2cureX AB Sweden 2CUREX
4SC AG Logo 4SC AG Germany VSC
Abera Bioscience AB Logo Abera Bioscience AB Sweden ABERA
ABIONYX Pharma Logo ABIONYX Pharma France ABNX
Abliva Logo Abliva Sweden ABLI
AB Science Logo AB Science France AB
Acticor Biotech Logo Acticor Biotech France ALACT
Active Biotech Logo Active Biotech Sweden ACTI
AcuCort AB Logo AcuCort AB Sweden ACUC